The superior cost of healthcare in the United States (US) and elsewhere can limit the ability of people to pay for and adhere to treatment method choices. Therefore, by way of their respective associations/bodies, providers can champion policy proposals that advocate a cap on out-of-pocket spending on all prescription prescription drugs according t